High Frequency of Epstein-Barr Virus and Absence of Papillomavirus in Breast Cancer Patients from Brazilian Northeast

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2022 Jul 28

PMID 35901341

Authors

Emanuele Silva De Oliveira

Marcia Valeria Pitombeira Ferreira

Paula Rahal

Martan Barroso Castelo Branco

Silvia Helena Barem Rabenhorst

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to determine the presence of Epstein-Barr Virus (EBV) and Human papillomavirus (HPV) in breast cancer with patients from Northeast of Brazil, considering the molecular subtypes and also taking in account the relation with TP53 immunoexpression.

Methods: Seventy-five samples of invasive breast carcinoma with no special type were selected from pathology archives at Federal University of Ceará. EBV was detected by In situ hybridization (ISH) and immunohistochemistry (IHC) and HPV was detected by PCR. ISH was performed using EBER1 probe (Shibata et al., 1991; Bacchi et al., 1996) while IHC was performed on histological formalin-fixed paraffin-embedded tissue samples (Hsu et al., 1981). PCR methodology (Haws et al., 2004) was used to amplify the genetic material of human papillomavirus. The amplification products were electrophoretic analyzed on 1% agarose gel. The data analyses were carried out using the statistical software EPINFO® version 6.04d and SPSS version 17.0 (SPSS Inc., Chicago, IL). Statistically significant differences were evaluated by the chi-square test and Fisher's exact test and correlations between groups were analyzed by Spearman's and Pearson's rank correlation coefficient.

Results: 69.4% of the cases were EBNA1 positives by IHC. EBNA1 positive tumors had lower Ki-67 index (0-40%), while EBNA1 negative cases had relevant higher Ki-67 index (41-100%) (p = 0.06). EBV was present in all tumor grades, with a high frequency in grade I and III tumors comparing to EBNA1 negative cases. No HPV positive cases were observed.

Conclusion: Regarding the results from this study, we support the hypothesis that EBV can be involved on breast tumorigenesis.

Citing Articles

Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management.

Wu M, Huang H, Tang Y, Ren X, Jiang X, Tian M Front Immunol. 2024; 15:1430544.

PMID: 39176086 PMC: 11338918. DOI: 10.3389/fimmu.2024.1430544.

The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature.

Rossi C, Inzani F, Cesari S, Rizzo G, Paulli M, Pedrazzoli P Pathogens. 2024; 13(6).

PMID: 38921749 PMC: 11206847. DOI: 10.3390/pathogens13060451.

Human papillomaviruses and breast cancer: A systematic review and meta‑analysis.

Karachalios C, Petousis S, Margioula-Siarkou C, Dinas K Oncol Lett. 2024; 27(2):75.

PMID: 38192655 PMC: 10773228. DOI: 10.3892/ol.2023.14208.

HPV-Associated Breast Cancer: Myth or Fact?.

Kudela E, Kudelova E, Kozubik E, Rokos T, Pribulova T, Holubekova V Pathogens. 2022; 11(12).

PMID: 36558844 PMC: 9786769. DOI: 10.3390/pathogens11121510.

References

Mastoraki A, Schizas D, Gkiala A, Ntella V, Hasemaki N, Pentara I . Human Papilloma Virus infection and breast cancer development: Challenging theories and controversies with regard to their potential association. J BUON. 2020; 25(3):1295-1301. View

Bratthauer G, Tavassoli F, OLeary T . Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992; 188(3):384-6. DOI: 10.1016/S0344-0338(11)81229-X. View

Hennig E, Suo Z, Thoresen S, Holm R, KVINNSLAND S, Nesland J . Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat. 1999; 53(2):121-35. DOI: 10.1023/a:1006162609420. View

Thorley-Lawson D . Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2002; 1(1):75-82. DOI: 10.1038/35095584. View

Glaser S, Ambinder R, DiGiuseppe J, Horn-Ross P, Hsu J . Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer. 1998; 75(4):555-8. DOI: 10.1002/(sici)1097-0215(19980209)75:4<555::aid-ijc10>3.0.co;2-8. View

Glaser S, Canchola A, Keegan T, Clarke C, Longacre T, Gulley M . Variation in risk and outcomes of Epstein-Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study. Cancer Causes Control. 2017; 28(4):273-287. DOI: 10.1007/s10552-017-0865-3. View

Hu Z, Ma D . The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018; 7(10):5217-5236. PMC: 6198240. DOI: 10.1002/cam4.1501. View

Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C . Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004; 31(4):292-7. DOI: 10.1016/j.jcv.2004.06.009. View

Khodabandehlou N, Mostafaei S, Etemadi A, Ghasemi A, Payandeh M, Hadifar S . Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer. 2019; 19(1):61. PMC: 6332859. DOI: 10.1186/s12885-019-5286-0. View

10.

Glenn W, Heng B, Delprado W, Iacopetta B, Whitaker N, Lawson J . Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One. 2012; 7(11):e48788. PMC: 3501510. DOI: 10.1371/journal.pone.0048788. View

11.

Yin H, Qu J, Peng Q, Gan R . Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol. 2018; 208(5):573-583. PMC: 6746687. DOI: 10.1007/s00430-018-0570-1. View

12.

Mohamed M, Al-Raawi D, Sabet S, El-Shinawi M . Inflammatory breast cancer: New factors contribute to disease etiology: A review. J Adv Res. 2015; 5(5):525-36. PMC: 4294279. DOI: 10.1016/j.jare.2013.06.004. View

13.

Glaser S, Hsu J, Gulley M . Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2004; 13(5):688-97. View

14.

de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X . No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2007; 109(1):55-8. DOI: 10.1007/s10549-007-9626-4. View

15.

Joshi D, Quadri M, Gangane N, Joshi R, Gangane N . Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009; 4(12):e8180. PMC: 2782138. DOI: 10.1371/journal.pone.0008180. View

16.

Brianti P, De Flammineis E, Mercuri S . Review of HPV-related diseases and cancers. New Microbiol. 2017; 40(2):80-85. View

17.

McCall S, Lichy J, Bijwaard K, Aguilera N, Chu W, Taubenberger J . Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst. 2001; 93(2):148-50. DOI: 10.1093/jnci/93.2.148. View

18.

Liang W, Tian H . Hypothetic association between human papillomavirus infection and breast carcinoma. Med Hypotheses. 2007; 70(2):305-7. DOI: 10.1016/j.mehy.2007.05.032. View

19.

Harkins L, Matlaf L, Soroceanu L, Klemm K, Britt W, Wang W . Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae. 2011; 1(1):8. PMC: 3063230. DOI: 10.1186/2042-4280-1-8. View

20.

Chen W, Chen Y, Bacchi M, Bacchi C, Alvarenga M, Weiss L . Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol. 1996; 148(1):17-23. PMC: 1861614. View